Filing Details

Accession Number:
0001245261-10-000010
Form Type:
4
Zero Holdings:
No
Publication Time:
2010-03-18 13:00:00
Reporting Period:
2010-03-16
Filing Date:
2010-03-18
Accepted Time:
2010-03-18 18:54:57
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1069530 Pain Therapeutics Inc PTIE Pharmaceutical Preparations (2834) 911911336
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1252240 Grant Schoenhard Chief Scientific Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2010-03-16 10,000 $4.40 58,187 No 4 P Direct
Common Stock Acquisiton 2010-03-16 25,000 $5.25 83,187 No 4 P Direct
Common Stock Disposition 2010-03-16 35,000 $6.13 48,187 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Common Stock Disposition 2010-03-16 25,000 $5.25 25,000 $5.25
Common Stock Common Stock Disposition 2010-03-16 10,000 $4.40 10,000 $4.40
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
720,000 2009-05-31 2015-05-31 No 4 X Direct
710,000 2010-02-28 2019-07-31 No 4 X Direct
Footnotes
  1. This sale is made pursuant to a plan intended to comply with rule 10b5-1(c). 35,000 shares of common stock were sold in twenty-eight (28) lots with prices ranging from $6.0726 to $6.18 per share.